Provider Events

Dr. Bradley Duhon*, Dr. Peter Whang* and Dr. Roland Kent* Invite You to Attend the SI-BONE Sacropelvic Evolution Program

Space is limited. Please RSVP by October 11th to secure your spot.

RSVP

SI-BONE SACROPELVIC EVOLUTION PROGRAM

November 10-11, 2023 | Austin Marriott South | 4415 South IH-35, Austin, TX 78744

The Sacropelvic Evolution Program is designed to bring together orthopedic surgeons and neurosurgeons who are currently completing spine fellowships or are residents with an interest in pursuing spine. This program will provide a comprehensive overview of the prevalence, diagnosis and treatment of sacroiliac (SI) joint dysfunction, pelvic trauma and sacropelvic instrumentation during deformity treatments.

Fifteen years ago, SI-BONE pioneered minimally invasive surgery for the SI joint, creating a durable and effective surgical treatment for a problem that had been misdiagnosed for decades. In recent years, SI-BONE has expanded its product portfolio to include technologies that are driving evolutions in trauma and pelvic fixation techniques.

The Sacropelvic Evolution Program will provide a great opportunity for you to join your colleagues, share your experiences, and learn about the latest treatment advancements.

We look forward to seeing you in Austin.

WHY SHOULD YOU ATTEND?

15 to 30% of chronic lower back pain is SI joint related¹

Up to 43% of symptomatic post-lumbar fusion patients have SI joint issues²

91% patient satisfaction with the iFuse Implant System®³

24% rate of pelvic fixation failure following adult spinal deformity surgery⁴

* Paid Consultant of SI-BONE, Inc.

¹ Bernard 1987; Schwarzer 1995; Maigne 1996; Sembrano 2009

² DePalma 2011.

³ Average of 12 studies (Rudolf 2012, Sachs 2013, Cummings 2013, Gaetani 2013, Sachs 2014, Rudolf 2014, Vanaclocha 2014, Duhon 2016, Polly 2016, Dengler 2019, Patel 2019, Whang 2019).

⁴ Eastlack RK, et al.; International Spine Study Group. Rates of Loosening, Failure, and Revision of Iliac Fixation in Adult Deformity Surgery. Spine. 2022 Jul 15;47(14):986-994. doi: 10.1097/BRS.0000000000004356. Epub 2022 Jul 15. PMID: 35819333.

Agenda:

Friday, November 10, 6-9 pm at Austin Marriott South - Sycamore Room A & B

6:00 – 9:00 p.m. Corporate Overview Sean Farley, Sr. Director, Medical Affairs, SI-BONE

Saturday, November 11:

7:00 a.m. Meet in hotel lobby

Transportation to facility

7:15 a.m. Shuttle to lab – MedtoMarket

2101 E St. Elmo Rd., Bldg 100

Austin, TX 78744

7:30 – 8:00 a.m. Registration and Breakfast

8:00 – 8:10 a.m. Anatomy and Physiology of the SI Joint

- Anatomical Review

- Biomechanical Properties of the SI Joint

8:10 – 8:20 a.m. SI Joint as A Pain Generator

- Why It Hurts

- Prevalence of Pain

- Burden of Disease

8:20 – 9:00 a.m. Diagnosis of the SI Joint

- History

- Physical Exam (multiple provocative tests)

- Imaging of the SI Joint

9:00 – 9:45 a.m. Review of Diagnostic Injection

- Intra-articular Pain and Injection

- Current Standard Technique

- Pre/Post evaluation

- Documentation

9:15 – 9:45 a.m. Hands-on Provocative Testing Lab

9:45 – 10:00 a.m. Break

10:00 – 10:15 a.m. Documentation

10:15 – 10:30 a.m. Surgical Technique Overview

- Historical Perspective of SI Joint Fusion

- MIS Options

- Why the Triangle?

- iFuse Surgical Technique

10:30 – 10:45 a.m. MIS SI Joint Fusion and Clinical Evidence

10:45 – 11:45 a.m. Sacropelvic Fixation & the SI joint

- Current methods of fixation

- Issues related to Sacropelvic fixation

- Review of Clinical Literature

- Science of iFuse Bedrock Granite®

- iFuse Bedrock Granite® Technique

12:00 – 1:00 p.m. Lunch

1:00 – 3:30 p.m. Surgical Lab

1:00 – 2:15 p.m. Group #1 – iFuse Lateral

Group #2 – iFuse Bedrock and Granite

2:15 – 3:30 p.m. Group #1 – iFuse Bedrock and Granite

Group #2 – iFuse Lateral

3:30 – 3:45 p.m. Closing Remarks

3:45 p.m. Transportation to Hotel

5:40 p.m. Meet in the Lobby

6:00 – 9:00 p.m. Reception

Space is limited. Please RSVP by October 11^th

The iFuse Implant System^® is intended for sacroiliac fusion for the following conditions:

• Sacroiliac joint dysfunction that is a direct result of sacroiliac joint disruption and degenerative sacroiliitis. This includes conditions whose symptoms began during pregnancy or in the peripartum period and have persisted postpartum for more than 6 months.
• To augment immobilization and stabilization of the sacroiliac joint in skeletally mature patients undergoing sacropelvic fixation as part of a lumbar or thoracolumbar fusion.
• Acute, non-acute, and non-traumatic fractures involving the sacroiliac joint.

If present, a pelvic fracture should be stabilized prior to the use of iFuse implants.

The iFuse TORQ^® Implant System is indicated for:

• Fusion of the sacroiliac joint for sacroiliac joint dysfunction including sacroiliac joint disruption and degenerative sacroiliitis.
• Augmenting immobilization and stabilization of the sacroiliac joint in skeletally mature patients undergoing sacropelvic fixation as part of a lumbar or thoracolumbar fusion.

The iFuse TORQ Implant System is also indicated for fracture fixation of the pelvis, including acute, non-acute, and non-traumatic fractures.

The iFuse TORQ Navigation instruments are intended to be used with the iFuse TORQ Implant System to assist the surgeon in precisely locating anatomical structures in iFuse TORQ Implant System procedures, in which the use of stereotactic surgery may be appropriate, and where reference to a rigid anatomical structure, such as the pelvis or vertebra, can be identified relative to the acquired image (CT, MR, 2D fluoroscopic image or 3D fluoroscopic image reconstruction) and/or an image data based model of the anatomy. iFuse TORQ Navigation instruments are intended to be used with the Medtronic^® StealthStation^® System.

The iFuse Bedrock Granite^® Implant System is intended for sacroiliac joint fusion for the following conditions:

• Sacroiliac joint dysfunction that is a direct result of sacroiliac joint disruption and degenerative sacroiliitis. This includes conditions whose symptoms began during pregnancy or in the peripartum period and have persisted postpartum for more than 6 months.
• To augment immobilization and stabilization of the sacroiliac joint in skeletally mature patients undergoing sacropelvic fixation as part of a lumbar or thoracolumbar fusion.
• Acute, non-acute, and non-traumatic fractures involving the sacroiliac joint.

When connected to compatible pedicle screw systems with 5.5- or 6.0-mm posterior rods made from either titanium alloy or cobalt chore alloy the iFuse Bedrock Granite Implant System is intended to provide immobilization and stabilization of spinal segments in skeletally mature patients as an adjunct to thoracolumbosacral fusion for the following acute and chronic instabilities or deformities of the thoracic, lumbar, and sacral spine:

• Degenerative disc disease (DDD) as defined by back pain of discogenic origin with degeneration of the disc confirmed by patient history and
  radiographic studies
• Spondylolisthesis
• Trauma (i.e., fracture or dislocation)
• Spinal stenosis
• Deformities or curvatures (i.e., scoliosis, kyphosis, and/or lordosis)
• Spinal tumor
• Pseudarthrosis
• Failed previous fusion

Please refer to the additional information section in the Instructions for Use on compatible pedicle screw system rods.

The iFuse Bedrock Granite Navigation instruments are intended to be used with the iFuse Bedrock Granite Implant System to assist the surgeon in precisely locating anatomical structures in iFuse Bedrock Granite Implant System procedures, in which the use of stereotactic surgery may be appropriate, and where reference to a rigid anatomical structure, such as the pelvis or vertebra, can be identified relative to the acquired image (CT, MR, 2D fluoroscopic image or 3D fluoroscopic image reconstruction) and/or an image data based model of the anatomy. iFuse Bedrock Granite Navigation instruments are intended to be used with the
Medtronic StealthStation System.

Healthcare professionals please refer to the Instructions For Use for indications, contraindications, warnings, and precautions at
www.si-bone.com/label. There are potential risks associated with iFuse procedures. They may not be appropriate for all patients
and all patients may not benefit. For information about the risks, please visit www.si-bone.com/risks.